Tong Ren Tang Technologies Co. Ltd. (TGRNF) Stock Competitors & Peer Comparison
See (TGRNF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TGRNF | $0.51 | +3.74% | 657.6M | 10.27 | $0.05 | +4.87% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.43% |
| RHHVF | $411.25 | -2.70% | 327.4B | 20.21 | $20.35 | +3.02% |
| RHHBF | $414.00 | -0.54% | 325.6B | 20.17 | $20.28 | +3.03% |
| RHHBY | $50.43 | -0.23% | 322B | 19.84 | $2.52 | +3.09% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $148.80 | +3.23% | 283.9B | 21.32 | $6.98 | +3.19% |
| SNYNF | $86.67 | -1.19% | 104.2B | 18.84 | $4.60 | +5.59% |
| GLAXF | $25.12 | +1.86% | 98.9B | 12.98 | $1.90 | +3.64% |
| CHGCF | $45.01 | -4.09% | 75.5B | 27.80 | $1.65 | +3.93% |
Stock Comparison
TGRNF vs BMYMP Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, TGRNF is priced at $0.51, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, TGRNF's ROE is +0.05%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, TGRNF is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check BMYMP's competition here
TGRNF vs RHHVF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, RHHVF has a market cap of 327.4B. Regarding current trading prices, TGRNF is priced at $0.51, while RHHVF trades at $411.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas RHHVF's P/E ratio is 20.21. In terms of profitability, TGRNF's ROE is +0.05%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, TGRNF is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check RHHVF's competition here
TGRNF vs RHHBF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, RHHBF has a market cap of 325.6B. Regarding current trading prices, TGRNF is priced at $0.51, while RHHBF trades at $414.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas RHHBF's P/E ratio is 20.17. In terms of profitability, TGRNF's ROE is +0.05%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, TGRNF is less volatile compared to RHHBF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check RHHBF's competition here
TGRNF vs RHHBY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, RHHBY has a market cap of 322B. Regarding current trading prices, TGRNF is priced at $0.51, while RHHBY trades at $50.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas RHHBY's P/E ratio is 19.84. In terms of profitability, TGRNF's ROE is +0.05%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, TGRNF is less volatile compared to RHHBY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check RHHBY's competition here
TGRNF vs AZNCF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, TGRNF is priced at $0.51, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, TGRNF's ROE is +0.05%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, TGRNF is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check AZNCF's competition here
TGRNF vs NVSEF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, NVSEF has a market cap of 283.9B. Regarding current trading prices, TGRNF is priced at $0.51, while NVSEF trades at $148.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas NVSEF's P/E ratio is 21.32. In terms of profitability, TGRNF's ROE is +0.05%, compared to NVSEF's ROE of +0.32%. Regarding short-term risk, TGRNF and NVSEF have similar daily volatility (0.00).Check NVSEF's competition here
TGRNF vs SNYNF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, SNYNF has a market cap of 104.2B. Regarding current trading prices, TGRNF is priced at $0.51, while SNYNF trades at $86.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas SNYNF's P/E ratio is 18.84. In terms of profitability, TGRNF's ROE is +0.05%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, TGRNF is less volatile compared to SNYNF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check SNYNF's competition here
TGRNF vs GLAXF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, GLAXF has a market cap of 98.9B. Regarding current trading prices, TGRNF is priced at $0.51, while GLAXF trades at $25.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas GLAXF's P/E ratio is 12.98. In terms of profitability, TGRNF's ROE is +0.05%, compared to GLAXF's ROE of +0.33%. Regarding short-term risk, TGRNF and GLAXF have similar daily volatility (0.00).Check GLAXF's competition here
TGRNF vs CHGCF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, CHGCF has a market cap of 75.5B. Regarding current trading prices, TGRNF is priced at $0.51, while CHGCF trades at $45.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas CHGCF's P/E ratio is 27.80. In terms of profitability, TGRNF's ROE is +0.05%, compared to CHGCF's ROE of +0.23%. Regarding short-term risk, TGRNF is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check CHGCF's competition here
TGRNF vs CHGCY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, CHGCY has a market cap of 75.2B. Regarding current trading prices, TGRNF is priced at $0.51, while CHGCY trades at $23.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas CHGCY's P/E ratio is 27.85. In terms of profitability, TGRNF's ROE is +0.05%, compared to CHGCY's ROE of +0.24%. Regarding short-term risk, TGRNF is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check CHGCY's competition here
TGRNF vs BAYRY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, BAYRY has a market cap of 40.2B. Regarding current trading prices, TGRNF is priced at $0.51, while BAYRY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas BAYRY's P/E ratio is -15.97. In terms of profitability, TGRNF's ROE is +0.05%, compared to BAYRY's ROE of -0.07%. Regarding short-term risk, TGRNF is less volatile compared to BAYRY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check BAYRY's competition here
TGRNF vs OTSKF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, OTSKF has a market cap of 33.7B. Regarding current trading prices, TGRNF is priced at $0.51, while OTSKF trades at $64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas OTSKF's P/E ratio is 14.95. In terms of profitability, TGRNF's ROE is +0.05%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, TGRNF and OTSKF have similar daily volatility (0.00).Check OTSKF's competition here
TGRNF vs OTSKY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, OTSKY has a market cap of 33.6B. Regarding current trading prices, TGRNF is priced at $0.51, while OTSKY trades at $31.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas OTSKY's P/E ratio is 14.91. In terms of profitability, TGRNF's ROE is +0.05%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, TGRNF is less volatile compared to OTSKY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check OTSKY's competition here
TGRNF vs DSNKY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, DSNKY has a market cap of 29B. Regarding current trading prices, TGRNF is priced at $0.51, while DSNKY trades at $15.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas DSNKY's P/E ratio is 18.12. In terms of profitability, TGRNF's ROE is +0.05%, compared to DSNKY's ROE of +0.16%. Regarding short-term risk, TGRNF is less volatile compared to DSNKY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check DSNKY's competition here
TGRNF vs DSKYF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, DSKYF has a market cap of 27B. Regarding current trading prices, TGRNF is priced at $0.51, while DSKYF trades at $14.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas DSKYF's P/E ratio is 16.89. In terms of profitability, TGRNF's ROE is +0.05%, compared to DSKYF's ROE of +0.16%. Regarding short-term risk, TGRNF is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check DSKYF's competition here
TGRNF vs ALPMY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, ALPMY has a market cap of 23.7B. Regarding current trading prices, TGRNF is priced at $0.51, while ALPMY trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas ALPMY's P/E ratio is 13.12. In terms of profitability, TGRNF's ROE is +0.05%, compared to ALPMY's ROE of +0.18%. Regarding short-term risk, TGRNF is less volatile compared to ALPMY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check ALPMY's competition here
TGRNF vs ALPMF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, ALPMF has a market cap of 23.7B. Regarding current trading prices, TGRNF is priced at $0.51, while ALPMF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas ALPMF's P/E ratio is 13.12. In terms of profitability, TGRNF's ROE is +0.05%, compared to ALPMF's ROE of +0.17%. Regarding short-term risk, TGRNF and ALPMF have similar daily volatility (0.00).Check ALPMF's competition here
TGRNF vs ORINY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, ORINY has a market cap of 22.9B. Regarding current trading prices, TGRNF is priced at $0.51, while ORINY trades at $40.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas ORINY's P/E ratio is 18.64. In terms of profitability, TGRNF's ROE is +0.05%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, TGRNF and ORINY have similar daily volatility (0.00).Check ORINY's competition here
TGRNF vs GIKLY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, GIKLY has a market cap of 14.2B. Regarding current trading prices, TGRNF is priced at $0.51, while GIKLY trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas GIKLY's P/E ratio is 15.40. In terms of profitability, TGRNF's ROE is +0.05%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, TGRNF and GIKLY have similar daily volatility (0.00).Check GIKLY's competition here
TGRNF vs RCDTF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, RCDTF has a market cap of 12.2B. Regarding current trading prices, TGRNF is priced at $0.51, while RCDTF trades at $60.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas RCDTF's P/E ratio is 22.90. In terms of profitability, TGRNF's ROE is +0.05%, compared to RCDTF's ROE of +0.24%. Regarding short-term risk, TGRNF and RCDTF have similar daily volatility (0.00).Check RCDTF's competition here
TGRNF vs CHJTF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, TGRNF is priced at $0.51, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, TGRNF's ROE is +0.05%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, TGRNF and CHJTF have similar daily volatility (0.00).Check CHJTF's competition here
TGRNF vs ORINF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, TGRNF is priced at $0.51, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas ORINF's P/E ratio is 18.98. In terms of profitability, TGRNF's ROE is +0.05%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, TGRNF and ORINF have similar daily volatility (0.00).Check ORINF's competition here
TGRNF vs CSPCY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, CSPCY has a market cap of 10.2B. Regarding current trading prices, TGRNF is priced at $0.51, while CSPCY trades at $3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas CSPCY's P/E ratio is 17.65. In terms of profitability, TGRNF's ROE is +0.05%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, TGRNF is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check CSPCY's competition here
TGRNF vs GIFOF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, TGRNF is priced at $0.51, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas GIFOF's P/E ratio is 12.46. In terms of profitability, TGRNF's ROE is +0.05%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, TGRNF and GIFOF have similar daily volatility (0.00).Check GIFOF's competition here
TGRNF vs GIFLF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, GIFLF has a market cap of 7.6B. Regarding current trading prices, TGRNF is priced at $0.51, while GIFLF trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas GIFLF's P/E ratio is 15.66. In terms of profitability, TGRNF's ROE is +0.05%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, TGRNF and GIFLF have similar daily volatility (0.00).Check GIFLF's competition here
TGRNF vs OPHLF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, TGRNF is priced at $0.51, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas OPHLF's P/E ratio is 15.65. In terms of profitability, TGRNF's ROE is +0.05%, compared to OPHLF's ROE of +0.09%. Regarding short-term risk, TGRNF and OPHLF have similar daily volatility (0.00).Check OPHLF's competition here
TGRNF vs KYKOF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, KYKOF has a market cap of 6.7B. Regarding current trading prices, TGRNF is priced at $0.51, while KYKOF trades at $12.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas KYKOF's P/E ratio is 16.05. In terms of profitability, TGRNF's ROE is +0.05%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, TGRNF and KYKOF have similar daily volatility (0.00).Check KYKOF's competition here
TGRNF vs OPHLY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, OPHLY has a market cap of 6.4B. Regarding current trading prices, TGRNF is priced at $0.51, while OPHLY trades at $4.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas OPHLY's P/E ratio is 14.71. In terms of profitability, TGRNF's ROE is +0.05%, compared to OPHLY's ROE of +0.09%. Regarding short-term risk, TGRNF is less volatile compared to OPHLY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check OPHLY's competition here
TGRNF vs DPHAY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, TGRNF is priced at $0.51, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, TGRNF's ROE is +0.05%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, TGRNF and DPHAY have similar daily volatility (0.00).Check DPHAY's competition here
TGRNF vs SNPHY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, SNPHY has a market cap of 3.9B. Regarding current trading prices, TGRNF is priced at $0.51, while SNPHY trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas SNPHY's P/E ratio is 17.23. In terms of profitability, TGRNF's ROE is +0.05%, compared to SNPHY's ROE of +0.13%. Regarding short-term risk, TGRNF is less volatile compared to SNPHY. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check SNPHY's competition here
TGRNF vs VRBCF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, VRBCF has a market cap of 3.6B. Regarding current trading prices, TGRNF is priced at $0.51, while VRBCF trades at $431.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas VRBCF's P/E ratio is 20.83. In terms of profitability, TGRNF's ROE is +0.05%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, TGRNF and VRBCF have similar daily volatility (0.00).Check VRBCF's competition here
TGRNF vs SNPHF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, TGRNF is priced at $0.51, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas SNPHF's P/E ratio is 15.48. In terms of profitability, TGRNF's ROE is +0.05%, compared to SNPHF's ROE of +0.17%. Regarding short-term risk, TGRNF and SNPHF have similar daily volatility (0.00).Check SNPHF's competition here
TGRNF vs HAWPY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, TGRNF is priced at $0.51, while HAWPY trades at $54.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas HAWPY's P/E ratio is 14.52. In terms of profitability, TGRNF's ROE is +0.05%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, TGRNF and HAWPY have similar daily volatility (0.00).Check HAWPY's competition here
TGRNF vs HAWPF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, TGRNF is priced at $0.51, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas HAWPF's P/E ratio is 12.90. In terms of profitability, TGRNF's ROE is +0.05%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, TGRNF and HAWPF have similar daily volatility (0.00).Check HAWPF's competition here
TGRNF vs PTKFF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, PTKFF has a market cap of 1.9B. Regarding current trading prices, TGRNF is priced at $0.51, while PTKFF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas PTKFF's P/E ratio is N/A. In terms of profitability, TGRNF's ROE is +0.05%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, TGRNF and PTKFF have similar daily volatility (0.00).Check PTKFF's competition here
TGRNF vs LYPHF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, LYPHF has a market cap of 1.6B. Regarding current trading prices, TGRNF is priced at $0.51, while LYPHF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas LYPHF's P/E ratio is 19.75. In terms of profitability, TGRNF's ROE is +0.05%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, TGRNF is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check LYPHF's competition here
TGRNF vs JCRRF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, JCRRF has a market cap of 383.7M. Regarding current trading prices, TGRNF is priced at $0.51, while JCRRF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas JCRRF's P/E ratio is 28.59. In terms of profitability, TGRNF's ROE is +0.05%, compared to JCRRF's ROE of +0.06%. Regarding short-term risk, TGRNF and JCRRF have similar daily volatility (0.00).Check JCRRF's competition here
TGRNF vs MAYNF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, MAYNF has a market cap of 125.9M. Regarding current trading prices, TGRNF is priced at $0.51, while MAYNF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas MAYNF's P/E ratio is -2.09. In terms of profitability, TGRNF's ROE is +0.05%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, TGRNF and MAYNF have similar daily volatility (0.00).Check MAYNF's competition here
TGRNF vs PTKFY Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, PTKFY has a market cap of 11.6M. Regarding current trading prices, TGRNF is priced at $0.51, while PTKFY trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas PTKFY's P/E ratio is 11.65. In terms of profitability, TGRNF's ROE is +0.05%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, TGRNF and PTKFY have similar daily volatility (0.00).Check PTKFY's competition here
TGRNF vs PSYGF Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, PSYGF has a market cap of 2.2M. Regarding current trading prices, TGRNF is priced at $0.51, while PSYGF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas PSYGF's P/E ratio is -0.19. In terms of profitability, TGRNF's ROE is +0.05%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, TGRNF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check PSYGF's competition here
TGRNF vs CRXTQ Comparison June 2026
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 657.6M. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, TGRNF is priced at $0.51, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.27, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, TGRNF's ROE is +0.05%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, TGRNF and CRXTQ have similar daily volatility (0.00).Check CRXTQ's competition here